Vertex Forward: Diving into type 1 diabetes | Vertex
A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. - The New York Times
Vertex eyes type 1 diabetes cure with biotech acquisition - PMLiVE
Vertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82. Scientific Sessions der American Diabetes Association | Business Wire
Vertex Type 1 Diabetes Research Stirs Hope for Stem Cell-Based 'Cure'
Vertex Expanding into Diabetes Cell Therapy with Plans to Acquire Semma
Vertex to acquire stem cell-derived diabetes treatment maker ViaCyte
Type 1 Diabetes Cures in Spotlight with Vertex Deal
Vertex snaps up diabetes stem cell rival | Nature Biotechnology
Cell Therapy For Type 1 Diabetes: Vertex Press Release
A single patient is producing insulin after treatment with Vertex's new diabetes cell therapy | Fierce Biotech
Vertex to buy Semma Therapeutics for $950m in cash
Vertex – type 1 diabetes vs stem cell therapy - The Boar
Vertex Stock Falls as FDA Places Clinical Hold on Diabetes Treatment | Barron's
FDA clears Vertex to continue dosing in diabetes cell therapy trial – PharmaLive
Vertex: Trial of New Type 1 Diabetes Cell Therapy Put on Hold - DSM
Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical Payoff | The Motley Fool
Vertex Releases New Data on Potential Cure for Type 1 Diabetes
Can Vertex Pharmaceuticals and Douglas Melton CURE Type 1 Diabetes? | VX880 - YouTube
Vertex has initial success in new diabetes project — MedWatch
Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami - World Stem Cell Summit
Vertex: FDA pausiert Diabetes-Studie – Aktie unter Druck - DER AKTIONÄR
Vertex's diabetes treatment hit with FDA hold
